Janssen wins patent case against Sandoz over macitentan drug

By James Gaughan ( June 2, 2022, 3:12 PM EDT) -- Pharmaceutical manufacturer Janssen Inc. will continue to be the only company in Canada to provide a specific medicine used in the treatment of pulmonary arterial hypertension, after winning a patent case in the Federal Court....

Related Sections